Losartan, an angiotensin receptor blocker (ARB), has been used for the prevention of aneurysms in mouse models to stabilize the aortic root in pediatric patients with MFS and also to ameliorate aggressive aortic disease by blocking TGF-β signaling [23]. This evidence concerns the gene TGFB1 and aneurysm.